Toxic shock syndrome toxin-1

Toxic Shock Syndrome Toxin-1
Toxic Shock Syndrome Toxin-1 (TSST-1) is a potent superantigen produced by certain strains of Staphylococcus aureus bacteria. It is a key virulence factor responsible for the development of toxic shock syndrome (TSS), a rare but serious condition characterized by fever, rash, low blood pressure, and multi-organ dysfunction.
Structure and Function[edit]
TSST-1 is a protein toxin composed of 22 kDa subunits that form a ring-shaped structure. It functions by binding to major histocompatibility complex class II molecules on antigen-presenting cells and T-cell receptors, leading to the activation of a large number of T cells. This massive immune response results in the release of pro-inflammatory cytokines, causing the symptoms associated with TSS.
Clinical Manifestations[edit]
Individuals exposed to TSST-1 may develop symptoms of TSS within a few days. These symptoms include high fever, hypotension, rash resembling a sunburn, and desquamation (peeling) of the skin. In severe cases, TSS can lead to organ failure and even death if not promptly treated.
Diagnosis and Treatment[edit]
Diagnosis of TSS typically involves clinical evaluation, laboratory tests to detect the presence of TSST-1 or other toxins, and ruling out other conditions with similar symptoms. Treatment often includes supportive care to stabilize the patient's condition, intravenous antibiotics to target the underlying bacterial infection, and management of complications such as shock and organ dysfunction.
Prevention[edit]
Preventing TSS involves practicing good hygiene, using tampons and menstrual cups properly, and promptly seeking medical attention for any signs of infection. Additionally, individuals with a history of TSS should avoid using tampons and consider alternative menstrual products.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
